Calcium Channel Blocker Selection Guide
Select Your Health Profile
Answer these questions to find the most appropriate calcium channel blocker for your situation.
When it comes to controlling high blood pressure, Plendil is a name many patients encounter, but it’s not the only option on the market. Understanding how Felodipine stacks up against other calcium channel blockers helps you and your doctor choose the right drug for your lifestyle and health profile.
Plendil is the brand name for Felodipine, a third‑generation dihydropyridine calcium channel blocker. It works by relaxing the smooth muscle in arterial walls, which lowers peripheral resistance and reduces blood pressure. Approved by the UK MHRA in 1995, Plendil is prescribed for hypertension and, in some cases, chronic stable angina.
How Felodipine Works
Felodipine belongs to the dihydropyridine subclass of calcium channel blockers (CCBs). By blocking L‑type calcium channels in vascular smooth muscle, it inhibits calcium influx, preventing contraction. The result is vasodilation, decreased systolic and diastolic pressure, and reduced cardiac afterload. Unlike non‑dihydropyridine CCBs (e.g., diltiazem), Felodipine has minimal effect on heart rate, making it a good choice for patients who cannot tolerate bradycardia.
Key Alternatives to Plendil
Several other CCBs are widely used for the same indications. Below are the most common alternatives, each with its own pharmacokinetic profile and side‑effect spectrum.
- Amlodipine is a long‑acting dihydropyridine CCB that offers once‑daily dosing and a smoother blood‑pressure curve.
- Nifedipine comes in both immediate‑release and prolonged‑release formulations; the latter is preferred for hypertension.
- Lercanidipine is a newer dihydropyridine with a favorable side‑effect profile, especially regarding peripheral edema.
- Diltiazem is a non‑dihydropyridine CCB that also slows conduction through the AV node, useful in patients with concurrent arrhythmias.
- Verapamil shares the non‑dihydropyridine class but has stronger negative inotropic effects, making it suitable for certain cardiac conditions.
Comparison Table: Plendil vs. Other CCBs
| Drug | Subclass | Typical Daily Dose | Onset of Action | Half‑life | Common Side Effects | Approx. UK Cost (per month) |
|---|---|---|---|---|---|---|
| Plendil (Felodipine) | Dihydropyridine | 5-10 mg | 2-4 h | 20-30 h | Headache, facial flushing, peripheral edema | £12-£18 |
| Amlodipine | Dihydropyridine | 5-10 mg | 6-12 h | 35-50 h | Swelling, dizziness, gum overgrowth | £8-£14 |
| Nifedipine (ER) | Dihydropyridine | 30-60 mg | 4-6 h | 12-24 h | Headache, flushing, reflex tachycardia | £10-£16 |
| Lercanidipine | Dihydropyridine | 10-20 mg | 3-4 h | 8-10 h | Less edema, mild headache | £15-£22 |
| Diltiazem | Non‑dihydropyridine | 120-360 mg (ER) | 2-3 h | 3-5 h | Bradycardia, constipation, edema | £20-£28 |
| Verapamil (ER) | Non‑dihydropyridine | 180-360 mg | 2-4 h | 4-7 h | Constipation, heart block, edema | £22-£30 |
When to Choose Plendil Over Alternatives
Plendil shines in a few specific scenarios:
- Kidney function: Felodipine is primarily metabolized by the liver with minimal renal excretion, making it safer for patients with moderate chronic kidney disease.
- Once‑daily convenience: Its long half‑life allows a single dose, supporting adherence.
- Low drug‑interaction risk: Felodipine does not inhibit CYP3A4 as strongly as some alternatives, reducing the chance of interaction with statins or certain antifungals.
When Alternatives Might Be Better
Even though Plendil is effective, other CCBs may be preferable depending on comorbidities.
- Amlodipine for edema‑prone patients: Its gradual onset often results in less peripheral swelling compared with Felodipine.
- Diltiazem or Verapamil for arrhythmias: Their AV‑node blocking properties help control atrial fibrillation or supraventricular tachycardia, which Felodipine does not.
- Lercanidipine for patients on multiple antihypertensives: Its neutral effect on hepatic enzymes makes it a good add‑on.
- Nifedipine (ER) for rapid blood‑pressure drops needed: Faster onset can be useful in hypertensive emergencies after initial stabilization.
Side‑Effect Profile Comparison
All CCBs share some class‑wide side effects-headache, flushing, and peripheral edema-but the frequency varies.
Felodipine tends to cause mild edema in 10‑15 % of users, whereas amlodipine’s rate climbs to 20‑30 % due to its longer exposure. Non‑dihydropyridines such as diltiazem often bring bradycardia and constipation, which are rare with Felodipine.
Understanding your tolerance level helps tailor the selection. For instance, a patient who already experiences ankle swelling from a diuretic may find amlodipine aggravating, making Plendil a better fit.
Drug Interactions to Watch
Because Felodipine is metabolized by CYP3A4, potent inhibitors (e.g., ketoconazole, ritonavir) can raise its plasma concentration, raising the risk of hypotension. However, the interaction magnitude is modest compared with amlodipine, which shows a stronger effect with the same inhibitors.
Another crucial interaction is with simvastatin. High‑dose simvastatin (>20 mg) plus Felodipine can increase statin levels, potentially leading to myopathy. Switching to pravastatin or rosuvastatin mitigates this risk.
Cost Considerations in the UK
Price often guides the final decision, especially for long‑term therapy. Generic felodipine tablets typically cost £12-£18 per month, whereas generic amlodipine is slightly cheaper, around £8-£14. Non‑dihydropyridine agents like diltiazem and verapamil tend to be pricier, ranging £20-£30 monthly, largely due to extended‑release formulations.
Prescription savings schemes, NHS repeat prescriptions, and pharmacy discount cards can further lower out‑of‑pocket expenses. Patients should ask their pharmacist about the cheapest equivalent brand.
Practical Tips for Switching or Starting Therapy
- Consult your GP or cardiologist before any change; abrupt cessation can cause rebound hypertension.
- If moving from a short‑acting CCB to Felodipine, start at the lowest dose (5 mg) and titrate after two weeks.
- Monitor blood pressure twice daily for the first week after a switch; adjust dose based on average readings.
- Watch for new swelling or dizziness; report persistent symptoms to your clinician.
- Keep a medication list handy, noting any CYP3A4 inhibitors you use (e.g., certain antibiotics).
Frequently Asked Questions
Is Plendil safe for pregnant women?
Felodipine is classified as Category C in the UK, meaning animal studies have shown risk and there are no well‑controlled studies in humans. It should only be used if the potential benefit justifies the potential fetal risk. Most clinicians prefer alternatives like labetalol during pregnancy.
Can I take Plendil with a statin?
Yes, but avoid high‑dose simvastatin. Combining Felodipine with low‑to‑moderate doses of pravastatin or rosuvastatin is generally safe. Always check with your prescriber.
What is the difference between Felodipine and Amlodipine?
Both are dihydropyridine CCBs, but amlodipine has a longer half‑life (up to 50 h) and a higher incidence of peripheral edema. Felodipine reaches peak levels faster and interacts less strongly with CYP3A4 inhibitors.
How quickly does Plendil lower blood pressure?
Clinical trials show a measurable reduction within 2‑4 hours, with the full antihypertensive effect stabilizing after about two weeks of consistent dosing.
Can I stop Plendil abruptly?
Abrupt discontinuation can lead to rebound hypertension. Tapering the dose under medical supervision is recommended.
Bottom Line
Plendil (Felodipine) offers a solid balance of efficacy, once‑daily dosing, and moderate cost, especially for patients with kidney concerns or those on multiple CYP3A4‑interacting drugs. However, alternatives like amlodipine or lercanidipine may provide better tolerance for edema‑prone individuals, while diltiazem and verapamil are preferable when heart‑rate control is also needed. The best choice hinges on your specific health profile, side‑effect tolerance, and budget. Talk to your GP or pharmacist, compare the side‑effect tables, and pick the medication that aligns with your lifestyle.
Kathryn Rude
October 24, 2025 AT 14:10Plendil? Meh 😒